Correction: A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy

Affiliations

• ¹ King's College London, Randall Centre for Cell and Molecular Biophysics, London, SE1 1UL, UK. johanna.prueller@kcl.ac.uk.
• ² King's College London, Randall Centre for Cell and Molecular Biophysics, London, SE1 1UL, UK.
• ³ King's College London, School of Biomedical Engineering and Imaging Sciences, St Thomas' Hospital, London, SE1 7EH, UK.
• ⁴ King's College London, Randall Centre for Cell and Molecular Biophysics, London, SE1 1UL, UK. peter.zammit@kcl.ac.uk.